Sevelamer

CHEMBL5314349 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

Rather than being absorbed into the body, this medication works entirely in the gut by binding dietary phosphate and preventing it from entering the bloodstream. It is used in dialysis patients and those with chronic kidney disease to manage dangerously high phosphate levels that can damage bones and blood vessels.

Terapötik Alanlar

Cardiovascular Disease Pain Management Asthma Epilepsy Migraine Schizophrenia Bipolar Disorder Generalized Anxiety Disorder Insomnia Chronic Kidney Disease Obesity Type 2 Diabetes Hypertension Chronic Pain Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Rather than being absorbed into the body, this medication works entirely in the gut by binding dietary phosphate and preventing it from entering the bloodstream. It is used in dialysis patients and those with chronic kidney disease to manage dangerously high phosphate levels that can damage bones and blood vessels.

Yes, Sevelamer is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5314349. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Sevelamer PillFYI'da

Hızlı Veriler

Eş Anlamlılar: 2

Dış Bağlantılar

ChEMBL CHEMBL5314349

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.